CLASS II ONGOING Device recall · Reported 5 Mar 2025 · FDA Enforcement Report

ASP Biotrace Auto Read 60 Steam BI Process Challenge Device recalled

Terragene is recalling ASP Biotrace Auto Read 60 Steam BI Process Challenge Device, distributed nationwide in the US. The recall was initiated on 15 Jan 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: F40062, F40064, F40072, F40074, F40101, F40116; UDI-DI - 07798375772624 (primary packaging), 07798375772877 (secondary packaging) containing IFU Rev.A R0.
Quantity recalled914 devices in the U.S.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1248-2025
FDA event ID
96176
Recalling firm
Terragene, Alvear, N/A
Classification
Class II
Status
Ongoing
Recall initiated
15 Jan 2025
FDA classified
27 Feb 2025
Reported
5 Mar 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Jan 2025Recall initiated by company
27 Feb 2025Classified by FDA+43 days
5 Mar 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Error in the IFU lists an incorrect incubation time on one occasion of 20 minutes rather than the correct incubation time of 60 minutes.

Product as listed by the FDA

ASP BIOTRACE Auto Read 60 Steam BI Process Challenge Device, REF 73135.

Where it was distributed

US Nationwide distribution in the states of CA and KY.

Nationwide CaliforniaKentucky

Questions about this recall

Why was it recalled?

Error in the IFU lists an incorrect incubation time on one occasion of 20 minutes rather than the correct incubation time of 60 minutes.

Which lots are affected?

Lot numbers: F40062, F40064, F40072, F40074, F40101, F40116; UDI-DI - 07798375772624 (primary packaging), 07798375772877 (secondary packaging) containing IFU Rev.A R0.

Where was it sold?

US Nationwide distribution in the states of CA and KY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Terragene

All 3
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIIntegron IT26-C Terragene Integron IT26-C recalledTerrageneOtherNationwide
DeviceCLASS IIBionova PCD (PCD222-C) recalled by TerrageneTerrageneOtherNationwide

Other Other Medical Devices recalls

All 13,908